Indutrade AB reports strong Q3 earnings and expands its portfolio through strategic acquisitions
Indutrade AB (NASDAQ OMX Nordic: INDT) announced its third‑quarter 2026 results on 23 October, showing a solid earnings lift that underscores the company’s resilience amid a competitive industrial trading landscape.
Earnings growth outpaces revenue gains
For the quarter ending 30 September, Indutrade posted SEK 804 million in earnings, up from SEK 674 million a year earlier. Per‑share earnings rose from SEK 1.85 to SEK 2.21. Revenue grew 13.1 % to SEK 8.871 billion from SEK 7.846 billion last year, reflecting a healthy mix of organic sales growth and the impact of newly acquired businesses.
The company’s operating performance, measured by EBITA, matched consensus expectations. EBITA reached SEK 1.358 million, slightly above the SEK 1.353 million forecast, translating into a 15.3 % margin versus the consensus of 15.2 %.
Order book and market outlook
Chief Executive Officer Bo Annvik highlighted the robustness of Indutrade’s order pipeline, noting that “the strengthened order book and continued high acquisition pace provide good prospects for the coming quarters.” He cited large, long‑term energy‑sector projects across Europe as a key driver of future demand, while acknowledging ongoing market uncertainty.
Strategic acquisitions reinforce product portfolio
Indutrade’s growth strategy is underpinned by a series of targeted acquisitions:
| Date | Target | Industry | Annual Turnover | Impact |
|---|---|---|---|---|
| 22 Oct 2026 | Schraner (Germany) | Fire‑protection systems, sensors | SEK 90 million | Adds specialist equipment and 35 employees to the Infrastructure & Construction segment |
| 21 Oct 2026 | Sinmed Sp. z o.o. (Poland) | Life‑science, single‑use medical consumables | SEK 130 million (≈ PLN 50 million) | Expands Indutrade’s footprint in medical and hygiene products, complementing existing industrial offerings |
These acquisitions, the 13th and 14th in Indutrade’s history, broaden the company’s geographical reach and product mix, positioning it to capture demand from both traditional industrial clients and the growing life‑science sector.
Financial health and market perception
With a market capitalization of SEK 9.48 billion and a price‑earnings ratio of 37.11, Indutrade is trading near the 52‑week high of SEK 272.2 (as of 15 October). The recent earnings beat and steady revenue growth have reinforced investor confidence, keeping the stock well above its 52‑week low of SEK 180.7.
Conclusion
Indutrade AB’s latest results demonstrate a company that is not only growing its core trading business but also strategically diversifying through acquisitions that align with its industrial and life‑science competencies. The combination of a healthy earnings profile, a robust order book, and an expanding product portfolio suggests that Indutrade is well positioned to navigate the complexities of the European industrial market while seizing new growth avenues.
